Psoriatic Arthritis

M. Elaine Husni, MD, MPH, spoke with Healio about treatment and management options in psoriatic arthritis, including lifestyle changes. “We now have really embraced the concept of wellness strategies,” said Husni, vice chair of rheumatology and director of the Arthritis and Musculoskeletal Center and staff physician in the Orthopedic and Rheumatologic Institute at Cleveland Clinic, and assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Healio spoke with Philip J. Mease, MD, about efforts needed to increase awareness of psoriatic arthritis among both patients and clinicians.

Healio spoke with Philip J. Mease, MD, about ongoing research in psoriatic arthritis.

Healio spoke with Philip J. Mease, MD, about factors to consider when making psoriatic arthritis treatment decisions.

Healio spoke with Philip J. Mease, MD, about non-pharmacological and complementary management options in psoriatic arthritis.

Healio spoke with Philip J. Mease, MD, about recent advancements in psoriatic arthritis.

Johnson & Johnson has settled its lawsuit with Amgen regarding the latter company’s Stelara biosimilar, clearing the way for a January 2025 release date in the United States, according to results of a federal court filing.

Patients with psoriatic arthritis and axial involvement experienced greater improvement when treated with upadacitinib 15 mg compared with placebo and adalimumab, according to data published in Arthritis Research & Therapy.

Healio spoke with Lourdes Perez-Chada, MD, MMSc, an instructor in dermatology and assistant director for Master of Medical Sciences in Clinical Investigation at Harvard Medical School, about how patients with psoriatic arthritis are impacted by sleep issues, and how rheumatologists and primary care physicians can address this issue.

As a kid, I would always say, “When I grow up, I’m going to be a doctor.”